PharmaHub · Other Pharma & Biotech · Global

Image Guided Therapy Systems Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

Image-guided therapy systems integrate medical imaging modalities such as MRI, CT, and ultrasound with interventional procedures to enable minimally invasive surgeries and diagnostics across multiple clinical specialties. The global market was valued at approximately $5.1 billion in 2024, with 2025 estimates ranging from $5.39 billion to $5.88 billion depending on methodology, and is projected to reach roughly $6.97 billion by 2030 at compound annual growth rates between 5% and 6.2%. Growth is propelled by aging populations, rising chronic disease prevalence, technological advances in imaging and AI-assisted navigation, and the clinical and economic advantages of less invasive treatment approaches. North America currently dominates, while Asia-Pacific is positioned for the fastest expansion due to healthcare infrastructure investment and growing medical tourism.

Market size · 2025
$5.6 billion
CAGR · 2025–2030
6.2%
Forecast · 2030
$7.6 billion
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $5.6bn2030 est: $7.6bn
Read the full Image Guided Therapy Systems Market report →

Market Overview

The image-guided therapy systems market encompasses diagnostic imaging equipment and interventional platforms that provide real-time visualization during surgical and minimally invasive procedures. These systems span MRI-guided, CT-guided, ultrasound-guided, and hybrid operating room environments, serving applications in oncology, cardiology, neurology, orthopedics, and other specialties. Global market size was estimated at approximately $5.1 billion in 2024, with 2025 valuations reported between $5.39 billion and $5.88 billion, and long-term projections reaching around $6.97 billion by 2030 at a compound annual growth rate of roughly 5% to 6.2%.

  • Global market size was approximately $5.1 billion in 2024
  • 2025 estimates range from $5.39 billion to $5.88 billion across research sources
  • Market projected to reach approximately $6.97 billion by 2030 with CAGRs between 5% and 6.2%

Growth Drivers

Demographic shifts toward older populations and the increasing global burden of chronic diseases are expanding the demand for image-guided interventions across oncology, cardiology, neurology, and orthopedic procedures. Advances in imaging resolution, AI-powered surgical navigation, and integration with robotic-assisted platforms are making minimally invasive treatments more precise, safer, and accessible to broader patient populations. Healthcare economics also favor adoption, as image-guided techniques reduce complication rates, shorten hospital stays, and deliver better long-term outcomes compared to open surgical alternatives.

  • Aging demographics and rising chronic disease prevalence are expanding the patient pool requiring image-guided interventions
  • Technological innovation in imaging resolution, AI-assisted navigation, and robotics integration is improving procedural precision
  • Cost-containment pressures favor adoption as image-guided techniques reduce complications, shorten stays, and improve outcomes
Want a deeper cut on Image Guided Therapy Systems Market? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

The market is segmented by imaging modality type, clinical application, and end-user setting, with MRI, CT, ultrasound, and hybrid navigation systems representing the primary technology platforms. North America commands the largest regional share, with the United States representing an estimated market exceeding $3 billion globally and forecast to grow from approximately $1.49 billion in 2024 to $2.35 billion by 2033. Asia-Pacific is expected to register the fastest growth rate, supported by healthcare infrastructure expansion, rising disposable incomes, medical tourism growth, and increased healthcare spending in China, India, and Japan.

  • North America holds the largest market share, with the United States alone exceeding $3 billion in valuation
  • The U.S. market is forecast to grow from $1.49 billion in 2024 to $2.35 billion by 2033
  • Asia-Pacific is projected to see the fastest growth due to infrastructure investment and medical tourism expansion

Trends and Outlook

What are the recent trends and outlook?

The integration of artificial intelligence and machine learning into imaging systems is enabling real-time anatomical recognition, automated targeting, and enhanced decision support during interventional procedures. Hybrid operating rooms combining multiple imaging modalities in a single suite are becoming standard equipment in major medical centers, supporting complex multidisciplinary interventions. Portable and point-of-care imaging solutions are expanding the reach of image-guided therapies into outpatient settings and resource-limited environments, while industry consolidation through mergers and acquisitions is expected to continue as larger organizations build integrated digital surgery ecosystems.

  • AI and machine learning integration is enabling real-time anatomical recognition and automated targeting during procedures
  • Hybrid operating rooms with multiple imaging modalities are becoming standard in major medical centers
  • Industry consolidation through mergers and acquisitions is expected as firms build integrated digital surgery ecosystems
Talk to a Claight analyst
Do you want to research Image Guided Therapy Systems Market?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.